Research

Researchers at leading Neurological and Psychiatric Research Partners around the world
are using NeuraMetrix TC in their research programs

Validation

NeuraMetrix’s clinical trial data and research papers on Parkinson’s, Huntington’s, and Depression confirm the device's accuracy and precision. Other neurological diseases and psychiatric disorders are in the process of validation.

Published papers:

Parkinson's: 'Fox Trial Finder Parkinson's Study'
Huntington's: ‘Monitoring the Motor Phenotype in Huntington’s Disease by Analysis of Keyboard Typing During Real Life Computer Use’

Research Programs

Researchers at leading academic institutions around the world are using NeuraMetrix TC in research programs involving:

ADHD
Alzheimer's Disease
Dementia
Depression
Huntington's Disease
Multiple Sclerosis
Neurodegenerative Disease
Parkinson's Disease
REM Sleep Behavior Disorder.

We are exploring research relationships for other neurological diseases and psychiatric disorders.

Concluded

Parkinson’s Disease | Michael J. Fox Foundation | U.S.A.
Parkinson’s Disease | Dutch University Medical Center | Netherlands, E.U.
REM Sleep Behavior Disorder | Philipps University | Germany, E.U.
Huntington’s Disease | University of Ulm | Germany, E.U.
Depression | University of Toronto | Canada
Multiple Sclerosis | UCSF | U.S.A.
ADHD | Sogn- and Fjordane University | Norway

In-process

Heart problems and Dementia | Boston University | U.S.A.

Headquarters

NeuraMetrix, Inc.
65 Merrimon Ave #1181
Asheville, NC 28801-2322
U.S.A.

Social

Facebook
LinkedIn
Twitter

About NeuraMetrix

NeuraMetrix is a Software as a Medical Device (SaMD) company. It offers a novel, unique, highly accurate digital biomarker to detect and monitor a range of Neurological diseases and Psychiatric disorders.

Change Language